Skip to main content

and
  1. Article

    Open Access

    CD1a+ survivin+ dendritic cell infiltration in dermal lesions of systemic sclerosis

    Proto-oncogene survivin is a member of the inhibitor of apoptosis (IAP) family of proteins. The presence of serous antibodies against survivin in patients with systemic sclerosis has been previously reported; ...

    Sho Mokuda, Tatsuhiko Miyazaki, Yoshifumi Ubara in Arthritis Research & Therapy (2015)

  2. No Access

    Article

    Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases

    Anti-cytokine therapy is reportedly useful in amyloid A (AA) amyloidosis complicating rheumatic diseases. However, to date no studies have directly compared the utility of tumour necrosis factor (TNF) inhibiti...

    Yasuaki Okuda, Makoto Ohnishi, Kenichiro Matoba, Kazuo Jouyama in Modern Rheumatology (2013)

  3. No Access

    Article

    Simultaneous quantitative analysis of the expression of CD64 and CD35 on neutrophils as markers to differentiate between bacterial and viral infections in patients with rheumatoid arthritis

    The expression level of CD64 on neutrophils can be used to differentiate between an infection and a disease flare in rheumatoid arthritis (RA) patients. However, the CD64 expression is elevated by both bacteri...

    Sho Mokuda, Osamu Doi, Kiyoshi Takasugi in Modern Rheumatology (2012)

  4. No Access

    Article

    Successful tocilizumab treatment in a patient with adult-onset Still’s disease complicated by chronic active hepatitis B and amyloid A amyloidosis

    We report successful tocilizumab (TCZ) use in a patient with adult-onset Still’s disease (AOSD) complicated by chronic hepatitis B (CHB) and AA amyloidosis (AAA). Treatments with corticosteroid and various typ...

    Dai Kishida, Yasuaki Okuda, Makoto Onishi, Masashi Takebayashi in Modern Rheumatology (2011)